Long-term survivors in stage IIIB/IV lung cancer – a 5 year retrospective analysis

D. Ferreira, A. Oliveira, J. Vieira, A. Barroso, S. Conde, A. Furtado, R. Nogueira, B. Parente (Vila Nova de Gaia, Portugal)

Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies
Session: Biology, diagnosis and rare tumours in thoracic malignancies
Session type: Thematic Poster Session
Number: 2540
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Ferreira, A. Oliveira, J. Vieira, A. Barroso, S. Conde, A. Furtado, R. Nogueira, B. Parente (Vila Nova de Gaia, Portugal). Long-term survivors in stage IIIB/IV lung cancer – a 5 year retrospective analysis. Eur Respir J 2007; 30: Suppl. 51, 2540

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Retrospective assessment of non small cell lung cancer stage IIIA-IIIB, treated with neoadjuvant chemotherapy
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010


Mode of early relapse in resectable I-IIIA NSCLC – prospective, controlled study
Source: Eur Respir J 2005; 26: Suppl. 49, 168s
Year: 2005

Predictors of radiation-induced lung toxicity in patients with locally advanced non small cell lung cancer (NSCLC): a retrospective analysis
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009

Characteristics of lung cancer patients in Serbia and subsequent treatment in advanced NSCLC over time – epidemiology study
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017

A prospective study of survival after surgery for early stage non-small cell lung cancer in patients with COPD
Source: International Congress 2015 – Risk assessment and prevention of complications in thoracic surgery
Year: 2015



Resectability after two different chemotherapy regimens: results of the first step of a phase II randomised trial in initially resectable stage I – IIIa nonsmall cell lung cancer conducted by the European lung cancer working party
Source: Eur Respir J 2003; 22: Suppl. 45, 162s
Year: 2003

Main reasons for a low accrual pattern in clinical trials of patients with advanced stage non-small cell lung cancer (NSCLC)
Source: Annual Congress 2008 - Influence of teaching models on skills and knowledge of medical doctors
Year: 2008


Epidemiological and clinical predictors of survival during the first year of the treatment in non-small cell lung cancer patients
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009

A preliminary comprehensive hormonal evaluation on a prospective group of patients (pts) with advanced lung cancer
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009

A multicenter phase II study of docetaxel (D) weekly in advanced non-small cell lung cancer (NSCLC) in elderly and/or poor performance status (PS) patients (pts): preliminary results of the 0202 GFPC study
Source: Annual Congress 2005 - Chemotherapy and palliative care
Year: 2005


Regular follow-up for patients irradiated for early stage nonsmall-cell lung cancer too!
Source: Eur Respir J 2002; 20: 1065-1066
Year: 2002


Early concurrent chemoradiotherapy for limited small cell lung cancer (LSCLC). Analysis of toxicity and survival of 30 consecutive patients
Source: Eur Respir J 2002; 20: Suppl. 38, 464s
Year: 2002

Predictors of long time mortality after lung cancer surgery. A retrospective cohort study
Source: Annual Congress 2008 - Risk assessment and treatment of complications in thoracic surgery patients
Year: 2008



Survival of patients operated for stage I non-small-cell lung cancer
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008


Pembrolizumab versus nivolumab as second and further line treatment in non-small cell lung cancer; a retrospective single-centre study
Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology
Year: 2020


Phase II study of S-1 with patient-reported outcome evaluation in elderly patients with previously untreated advanced non-small cell lung cancer
Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies
Year: 2017




A multicenter phase II study of carboplatin/vinorelbine in advanced non-small cell lung cancer (NSCLC) in elderly patients (GFPC 9902)
Source: Eur Respir J 2003; 22: Suppl. 45, 30s
Year: 2003

Survival impact of surgery in the treatment of stage IIIB-IVA non-small cell lung cancer
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018


A retrospective analysis of risk factors for Durvalumab related interstitial lung disease after chemoradiotherapy in Stage III NSCLC
Source: Virtual Congress 2020 – Localised non-small cell lung cancer
Year: 2020


Renal impairment during pemetrexed maintenance in patients with advanced nonsmall cell lung cancer: a cohort study
Source: Eur Respir J, 52 (4) 1800884; 10.1183/13993003.00884-2018
Year: 2018